je.st
news
Cell Therapeutics soars 24 percent after drug deal with Baxter
2013-11-16 09:10:33| Biotech - Topix.net
The two companies agreed to jointly develop and market the drug, which is being tested in a late-stage trial, in a deal that could fetch Cell Therapeutics' up to $362 million, including an equity investment by Baxter.
Tags: with
cell
deal
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||